Uncategorized

Pfizer Stock Falls. It’s Halted Development of New Weight-Loss Drug. – Barron’s

Posted on Author Tim Hodges Comments Off on Pfizer Stock Falls. It’s Halted Development of New Weight-Loss Drug. – Barron’s
  1. Pfizer Stock Falls. It’s Halted Development of New Weight-Loss Drug.  Barron’s
  2. Pfizer scraps daily weight loss pill after liver injury in one patient  CNBC
  3. Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out  MarketWatch
  4. Pfizer Abandons Obesity Pill After Liver Injury in Setback  Bloomberg.com
  5. Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron  Business Wire